Detalhe da pesquisa
1.
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.
Blood
; 139(23): 3366-3375, 2022 06 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35081255
2.
[Future prospects for the development of novel agents for acute myeloid leukemia].
Rinsho Ketsueki
; 65(5): 353-361, 2024.
Artigo
Japonês
| MEDLINE | ID: mdl-38825514
3.
Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.
Cancer Sci
; 114(5): 2098-2108, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36793248
4.
Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan.
Cancer Sci
; 113(12): 4258-4266, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35689544
5.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med
; 381(18): 1728-1740, 2019 10 31.
Artigo
Inglês
| MEDLINE | ID: mdl-31665578
6.
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.
Int J Mol Sci
; 23(9)2022 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35563085
7.
[Hematopoietic cell transplantation for FLT3-mutated acute myeloid leukemia].
Rinsho Ketsueki
; 63(9): 1242-1251, 2022.
Artigo
Japonês
| MEDLINE | ID: mdl-36198550
8.
Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance.
BMC Cancer
; 21(1): 879, 2021 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34332580
9.
Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.
Int J Clin Oncol
; 26(11): 2131-2141, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34363558
10.
[Lineage switch from T-lymphoblastic leukemia to myeloid leukemia at relapse].
Rinsho Ketsueki
; 62(7): 721-726, 2021.
Artigo
Japonês
| MEDLINE | ID: mdl-34349054
11.
Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine.
BMC Cancer
; 20(1): 984, 2020 Oct 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33046037
12.
Genetic abnormalities and pathophysiology of MDS.
Int J Clin Oncol
; 24(8): 885-892, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31093808
13.
[Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
Rinsho Ketsueki
; 60(7): 800-809, 2019.
Artigo
Japonês
| MEDLINE | ID: mdl-31391370
14.
[New therapeutic agents for acute myeloid leukemia].
Rinsho Ketsueki
; 60(9): 1108-1119, 2019.
Artigo
Japonês
| MEDLINE | ID: mdl-31597834
15.
Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by 18F-FLT PET/MRI.
Ann Hematol
; 102(7): 1957-1959, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37150795
16.
Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001-2005 using the Japan Adult Leukemia Study Group AML201 protocols.
Support Care Cancer
; 26(12): 4187-4198, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29860713
17.
[Evaluation of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematological Malignancies Using MASCC Antiemesis Tool(MAT)].
Gan To Kagaku Ryoho
; 45(1): 45-50, 2018 Jan.
Artigo
Japonês
| MEDLINE | ID: mdl-29362306
18.
An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.
Br J Haematol
; 198(5): e75-e77, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35765195
19.
Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.
Support Care Cancer
; 25(11): 3515-3521, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28584934
20.
Lobar Hemorrhage Induced by Acquired Factor XIII Deficiency in a Patient with Cerebral Amyloid Angiopathy.
J Stroke Cerebrovasc Dis
; 26(10): e203-e205, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28801214